Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0862
+0.0072 (9.11%)
Apr 15, 2026, 3:53 PM EST
Galera Therapeutics Market Cap
Galera Therapeutics has a market cap or net worth of $6.5 million as of April 16, 2026. Its market cap has increased by 132.34% in one year.
Market Cap
6.50M
Enterprise Value
2.71M
Revenue
n/a
Ranking
n/a
PE Ratio
0.13
Stock Price
$0.09
Market Cap Chart
Since November 7, 2019, Galera Therapeutics's market cap has decreased from 292.35M to 6.50M, a decrease of -97.77%. That is a compound annual growth rate of -44.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 5.95M | 258.64% |
| Dec 31, 2025 | 1.66M | -51.98% |
| Dec 31, 2024 | 3.46M | -56.28% |
| Dec 29, 2023 | 7.91M | -81.38% |
| Dec 30, 2022 | 42.47M | -65.01% |
| Dec 31, 2021 | 121.35M | -52.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HST Global | 8.91M |
| Curative Biotechnology | 8.37M |
| BetterLife Pharma | 8.01M |
| NKGen Biotech | 7.84M |
| Synlogic | 7.46M |
| TRON Group | 6.68M |
| Orgenesis | 5.87M |
| AccuStem Sciences | 5.79M |